title: [Effects of medium-term treatment of acebutolol on lipid profile].
abstract: The effects of a 12-week treatment with acebutolol on serum lipids have been studied in 18 patients. Acebutolol was given as a 400-, 600-, or 800-mg single daily dose in the morning. Standing and supine blood pressure diminished significantly, whereas the major indexes of lipid metabolism such as total serum cholesterol, HDL-cholesterol, triglycerides, and plasma lipoproteins were not significantly affected. The treatment was well tolerated.
authors.affiliation: Servizio per l'Ipertensione Arteriosa e le Nefropatie, Policlinico Umberto I, Roma.
authors.forename: A
authors.initials: A
authors.lastname: Bossini
authors.forename: C
authors.initials: C
authors.lastname: Di Veroli
mesh_terms: D000070:Acebutolol / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged
chemical_list: D008055:Lipids; D000070:Acebutolol
vernacular_title: Effetto sul quadro lipidico di un trattamento a medio termine con acebutololo.